AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) saw a large growth in short interest in February. As of February 15th, there was short interest totalling 322,700 shares, a growth of 23.1% from the January 31st total of 262,200 shares. Based on an average daily volume of 3,200 shares, the days-to-cover ratio is currently 100.8 days.

AstraZeneca Stock Performance

Shares of AZNCF opened at $149.25 on Friday. The stock has a 50-day moving average of $140.65 and a 200-day moving average of $144.87. AstraZeneca has a one year low of $120.64 and a one year high of $175.00.

AstraZeneca Increases Dividend

The company also recently disclosed a dividend, which will be paid on Monday, March 24th. Stockholders of record on Friday, February 21st will be issued a dividend of $2.10 per share. This is an increase from AstraZeneca’s previous dividend of $1.00. The ex-dividend date is Wednesday, February 19th. AstraZeneca’s payout ratio is currently 343.14%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.